167 related articles for article (PubMed ID: 28101228)
1. Increased expression of PDIA3 and its association with cancer cell proliferation and poor prognosis in hepatocellular carcinoma.
Takata H; Kudo M; Yamamoto T; Ueda J; Ishino K; Peng WX; Wada R; Taniai N; Yoshida H; Uchida E; Naito Z
Oncol Lett; 2016 Dec; 12(6):4896-4904. PubMed ID: 28101228
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
[TBL] [Abstract][Full Text] [Related]
3. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells.
Ko E; Kim JS; Ju S; Seo HW; Chang Y; Kang JA; Park SG; Jung G
Hepatology; 2018 Nov; 68(5):1851-1864. PubMed ID: 29672884
[TBL] [Abstract][Full Text] [Related]
4. Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer.
Shimoda T; Wada R; Kure S; Ishino K; Kudo M; Ohashi R; Fujita I; Uchida E; Yoshida H; Naito Z
Oncol Rep; 2019 Apr; 41(4):2265-2272. PubMed ID: 30720117
[TBL] [Abstract][Full Text] [Related]
5. Protein disulfide-isomerase A3 significantly reduces ischemia-induced damage by reducing oxidative and endoplasmic reticulum stress.
Yoo DY; Cho SB; Jung HY; Kim W; Lee KY; Kim JW; Moon SM; Won MH; Choi JH; Yoon YS; Kim DW; Choi SY; Hwang IK
Neurochem Int; 2019 Jan; 122():19-30. PubMed ID: 30399388
[TBL] [Abstract][Full Text] [Related]
6. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.
Tu Z; Ouyang Q; Long X; Wu L; Li J; Zhu X; Huang K
Front Immunol; 2022; 13():837512. PubMed ID: 35401558
[TBL] [Abstract][Full Text] [Related]
7. Combination of CALR and PDIA3 is a potential prognostic biomarker for non-small cell lung cancer.
Wang K; Li H; Chen R; Zhang Y; Sun XX; Huang W; Bian H; Chen ZN
Oncotarget; 2017 Nov; 8(57):96945-96957. PubMed ID: 29228584
[TBL] [Abstract][Full Text] [Related]
8. The role of PDIA3 in oral squamous cell carcinoma and its value as A diagnostic and prognostic biomarker.
Wang L; Wang X; Zhang J; Duan J; Tang C; Zhang L; Zeng H; Li H; Li Y; Zhou Y
Heliyon; 2023 Dec; 9(12):e22596. PubMed ID: 38213579
[TBL] [Abstract][Full Text] [Related]
9. Protein disulfide isomerase A3-specific Th1 effector cells infiltrate colon cancer tissue of patients with circulating anti-protein disulfide isomerase A3 autoantibodies.
Caorsi C; Niccolai E; Capello M; Vallone R; Chattaragada MS; Alushi B; Castiglione A; Ciccone G; Mautino A; Cassoni P; De Monte L; Álvarez-Fernández SM; Amedei A; Alessio M; Novelli F
Transl Res; 2016 May; 171():17-28.e1-2. PubMed ID: 26772958
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
[TBL] [Abstract][Full Text] [Related]
11. Tat-protein disulfide-isomerase A3: a possible candidate for preventing ischemic damage in the spinal cord.
Yoo DY; Cho SB; Jung HY; Kim W; Choi GM; Won MH; Kim DW; Hwang IK; Choi SY; Moon SM
Cell Death Dis; 2017 Oct; 8(10):e3075. PubMed ID: 28981094
[TBL] [Abstract][Full Text] [Related]
12. Expression and Prognostic Significance of PDIA3 in Cervical Cancer.
Zhang J; Li H; Li H; Lin D; Wang X; Wang K
Int J Genomics; 2022; 2022():4382645. PubMed ID: 36406049
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of protein disulphide isomerase A3 and phosphorylated signal transducer and activator of transcription 3 in cervical carcinoma.
Abdullatif A; Abdelrahman AE; Bakry A; Gharieb SA; Ramadan MS; Wasfy MA; Abdelwanis AH; Fouad EM
Contemp Oncol (Pozn); 2024; 28(1):51-62. PubMed ID: 38800530
[TBL] [Abstract][Full Text] [Related]
14. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
15. Expression of protein disulfide isomerase A3 precursor in colorectal cancer.
Yang Z; Liu J; Shi Q; Chao Y; Di Y; Sun J; Zhang J; Huang L; Guo H; He C
Onco Targets Ther; 2018; 11():4159-4166. PubMed ID: 30050307
[TBL] [Abstract][Full Text] [Related]
16. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression.
Zhu Y; Cai L; Guo J; Chen N; Yi X; Zhao Y; Cai J; Wang Z
Tumour Biol; 2016 Oct; 37(10):14009-14023. PubMed ID: 27492604
[TBL] [Abstract][Full Text] [Related]
17. P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.
Zou H; Wen C; Peng Z; Shao YΥ; Hu L; Li S; Li C; Zhou HH
Oncol Rep; 2018 Feb; 39(2):501-510. PubMed ID: 29207176
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]